Fig. 2From: The biomarkers of hyperprogressive disease in PD-1/PD-L1 blockage therapyPossible biomarkers in the tumor microenvironment after ICI therapy, including exhausted T cells, Treg cells, M2 TAMs, and MDSCsBack to article page